medius KLINIKEN gemeinnützige GmbH

Essential steps in primary care management of older people with Type 2 diabetes: an executive summary on behalf of the European geriatric medicine society (EuGMS) and the European diabetes working party for older people (EDWPOP) collaboration (2023) Bourdel-Marchasson I, Maggi S, Abdelhafiz A, Bellary S, Demurtas J, Forbes A, Ivory P, et al. Journal article CHARACTERIZATION OF RELAPSES IN PATIENTS WITH GIANT CELL ARTERITIS (GCA) PATIENTS- DATA FROM THE REAL-LIFE TREATMENT AND SAFETY (REATS)-GCA COHORT (2022) Schönau V, Corte G, Ott S, Tascilar K, Hartmann F, Manger B, Hellmich B, et al. Conference contribution Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease (2022) Grueter T, Moellers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, et al. Journal article The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis (2021) Iking-Konert C, Wallmeier P, Arnold S, Adler S, De Groot K, Hellmich B, Hoyer BF, et al. Journal article Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen (2021) Schmidt C, Bachmann O, Baumgart DC, Goetz M, Drvarov O, Kucharzik TF, Kuehbacher T, et al. Journal article S2k-Leitlinie: Management der Großgefäßvaskulitiden (2020) Schirmer JH, Aries PM, Balzer K, Berlit P, Bley TA, Buttgereit F, Czihal M, et al. Journal article, Review article S2k-Leitlinie (Kurzfassung): Management der Großgefäßvaskulitiden (2020) Schirmer JH, Aries PM, Balzer K, Berlit P, Bley TA, Buttgereit F, Czihal M, et al. Journal article, Review article Diabetes mellitus in old age Diabetes mellitus im Alter (2020) Zeyfang A, Zeeh J, Bahrmann A, Kugler JN, Heppner HJ Journal article S2k Guideline Diagnosis, Therapy and Follow-up of Diabetes mellitus in Old Age (2018) Bahrmann A, Bahrmann P, Baumann J, Bauer J, Bruckel E, Dreyer M, Freitag M, et al. Journal article Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease (2018) Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al. Journal article